Forventes på lager: 28-05-2020
So far more than 1000 trials are currently ongoing with gene and cell therapies. Cure is no longer a dream for several monogenic disorders. However there is still uncertainty on how those products will be accessed by patients and at what price. This book aim to show how the regulatory environment has evolved to analyze and review those therapies.
| Forlag | Taylor & Francis Ltd |
| Forfattere | Eve Hanna, Mondher (Professor of Public Health at Aix-Marseille University Toumi |
| Type | Bog |
| Format | Paperback / softback |
| Sprog | Engelsk |
| Udgivelsesdato | 28-05-2020 |
| Første udgivelsesår | 2020 |
| Serie | Pharmaceuticals, Health Economics and Market Access |
| Illustrationer | 14 Tables, black and white; 100 Illustrations, black and white |
| Originalsprog | United Kingdom |
| Sideantal | 146 |
| Indbinding | Paperback / softback |
| Forlag | Taylor & Francis Ltd |
| Sideoplysninger | 146 pages, 14 Tables, black and white; 100 Illustrations, black and white |
| Mål | 157 x 234 x 15 |
| ISBN-13 / EAN-13 | 9780367408091 |